SCHEMBL29317070

SCHEMBL29317070

CC1CC2(CCN(CC3CNC3)CC2)C1

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.35
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25027097 0.83 ACHE (0.39) ACHE
SCHEMBL25026748 0.80 TSHR (0.32) TSHR
SCHEMBL25856125 0.79 TSHR (0.37) TSHR
SCHEMBL25664620 0.79 ACHE (0.61) ACHE
SCHEMBL24480556 0.79 ACHE (0.35) ACHE
SCHEMBL24480376 0.77 ACHE (0.42) ACHE
SCHEMBL25924747 0.77 TSHR (0.35) TSHR
SCHEMBL24319180 0.75 ACHE (0.61) ACHE
SCHEMBL25477641 0.75 ACHE (0.33) ACHE
SCHEMBL25571652 0.73 CHRM5 (0.40) ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4397661-A1 COMPOUND FOR DEGRADATION OF BCL-2 FAMILY PROTEINS AND MEDICAL APPLICATION THEREOF Xizang Haisco Pharmaceutical Co., Ltd. (CN) 2024-07-10 EP disclosed